GNLX — GENELUX Corp

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1231457 ·
Last close
$2.00
Market Cap
$90.49M
52W High
$5.89
52W Low
$1.77
ADV30
384,999
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -10,397,000 -10,285,000 20,612,000 9,445,000 11,434,000
Jun 2026 0 — -9,645,000 -9,471,000 26,205,000 9,184,000 10,092,000
Mar 2026 0 — -9,171,000 -8,928,000 32,372,000 9,273,000 9,451,000
Dec 2025 8,000 — -9,412,000 -9,247,000 19,027,000 5,333,000 7,483,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-25,277,000
Investing CF
$8,714,000
Financing CF
$19,201,000
CapEx
$-3,406,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.82
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-301,937,000
Inventory
—
Receivables
—
ST Investments
$9,486,000
EBIT TTM
$-36,422,000
Pretax Income TTM
$-35,596,000
Interest Exp TTM
—
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$8,000
EBITDA
$-36,280,000
Free Cash Flow
$-15,252,750
Enterprise Value
$95,331,888
Total Cash
$18,670,000
Total Debt
$2,420,000
Shares Out
45,245,335
Trailing EPS
$-0.86
Book Value
$0.36
ROE
-177.9%
ROA
-77.9%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 8,000 -33,214,000 -32,145,000 19,027,000 7,483,000 11,544,000 -25,268,000
Dec 2024 8,000 -31,696,000 -29,869,000 34,716,000 8,442,000 26,274,000 -21,228,000
Dec 2023 170,000 -24,165,000 -28,297,000 27,893,000 8,420,000 19,473,000 -20,275,000
Dec 2022 11,068,000 -3,013,000 -5,207,000 5,531,000 41,314,000 -35,783,000 -3,571,000

TTM Snapshot

Revenues TTM
$-100,000
NetIncome TTM
$-35,596,000
OpCashFlow TTM
—
Assets (Latest)
$26,205,000
Forward EPS
$-0.74

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $2.24 · call volume: 3,947 · put volume: 0
Expected Move to 2026-12-18: ±$1.35 (60.27%) — implied range $0.89 – $3.59 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
NKTX Nkarta, Inc. $89.53M $1.25 —
HURA TuHURA Biosciences, Inc./NV $89.22M $1.40 —
PMVP PMV Pharmaceuticals, Inc. $92.15M $1.22 —
ANIX Anixa Biosciences Inc $92.82M $2.67 —
CPIX CUMBERLAND PHARMACEUTICALS INC $86.96M $5.80 —

News headlines (Yahoo Finance, 1h cache)

Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates
2026-11-16 21:14 · Yahoo
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
2026-08-13 20:20 · Yahoo
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
2026-06-30 12:00 · Yahoo
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
2026-05-07 20:15 · Yahoo
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
2026-09-09 20:01 · Yahoo
Attovia Therapeutics Appoints John W. Smither to Board of Directors
2026-07-15 12:30 · Yahoo
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
2026-03-19 20:15 · Yahoo
Genelux Corporation to Participate in Upcoming Conferences
2026-02-18 13:00 · Yahoo
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
2026-01-12 21:00 · Yahoo
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
2026-01-08 14:13 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.